These applications with committed investment of Rs 5,355.44 crore and expected employment generation of about 11,210 have been approved by the government under the PLI Scheme for Bulk Drugs
India To Import 4.5 Lakh Remdesivir Vials Amid Rising Demand For Antiviral Drug
by Swarajya Staff - May 1, 2021 06:32 AM
Remdesivir
The Government of India has started importing the vital drug Remdesivir from other countries to ease out the shortage of Remdesivir in the country. The first Consignment of 75,000 vials reached India on Friday (30 April).
HLL Lifecare Ltd, a Government of India owned company has ordered 4,50,000 vials of Remdesivir from M/s Gilead Sciences Inc USA and Egyptian Pharma Company, M/s Eva Pharma.
It is expected that Gilead Sciences Inc, USA will dispatch 75,000 to 1,00,000 vials in the next one or two days. Further one lakh quantities will also be supplied before or by 15 May. EVA pharma will supply approximately 10,000 vials initially followed by 50,000 vials every 15 days or till July, Ministry of Chemicals and Fertilizers said in a statement.
Modi Govt Ramps Up Remdesivir Production From 40 Lakh Vials Per Month To 90 Lakh Vials Per Month
Remdesivir
Minister of State for Chemicals and Fertilizers Mansukh Mandaviya informed that 25 new manufacturing sites for Remdesivir s production have been approved since 12 April.
He said, âProduction capacity is now ramped up to more than 90 lakhs vials per month, earlier it was 40 lakhs vials per month. Very soon, three lakh vial per day will be produced. Monitoring is being done on a daily basis. We would not leave any stone unturned to supply Remdesivir.â
The Central government on Wednesday (21 April) made interim allocation of the key anti-viral drug for 19 states/Union Territories for the period up to 30 April.